ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,297.10
0.00%
Dow Jones
39,869.38
0.00%
US Dollar vs MXN
16.66375
-0.10%
Brent Oil
83.415
0.25%
Bitcoin
66,460.85
1.87%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Zai Lab Ltd (ZLAB)

  7. Zai Lab Ltd (ZLAB) Noticias

ZLAB Zai Lab Ltd

19.93
0.00 (0.00%)
Pre Mercado
Última actualización: 03:08:29
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Zai Lab Ltd ZLAB NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 19.93 03:08:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
19.93
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
16/5/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202406:30BWZai Lab Announces Participation in May and June Investor..
15/5/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/5/202412:22EDGAR2Form 144 - Report of proposed sale of securities
14/5/202406:30BWZai Lab Announces Acceptance of Supplemental Biologics..
12/5/202419:20BWZai Lab Announces Approval of AUGTYRO™ (repotrectinib) for..
08/5/202415:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:09EDGAR2Form 8-K - Current report
08/5/202415:05BWZai Lab Announces First Quarter 2024 Financial Results and..
15/4/202406:30BWZai Lab to Announce First Quarter 2024 Financial Results and..
11/4/202406:30BWZai Lab Statement on Executive Management Team’s Agreement..
02/4/202406:30BWZai Lab Presentations at AACR 2024 Annual Meeting to..
01/4/202406:30BWZai Lab Partner Bristol Myers Squibb Announces Pivotal..
27/3/202408:29BWZai Lab Partner Novocure Announces METIS Phase 3 Clinical..
13/3/202418:05BWZai Lab to Present Data Highlighting ZL-1310, a Novel..
06/3/202415:01BWZai Lab to Present Final Overall Survival (OS) Data from..
06/3/202406:30BWZai Lab Announces Participation in March Investor Conference
04/3/202415:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:20EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202415:12EDGAR2Form 8-K - Current report
27/2/202415:05BWZai Lab Announces Full-Year 2023 Financial Results and..
08/2/202415:37EDGAR2Form 8-K - Current report
25/1/202415:15BWZai Lab to Announce Full-Year 2023 Financial Results and..
10/1/202416:12BWZai Lab Announces The New England Journal of Medicine..
03/1/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202418:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202414:50EDGAR2Form 144 - Report of proposed sale of securities
03/1/202414:47EDGAR2Form 144 - Report of proposed sale of securities
03/1/202414:42EDGAR2Form 144 - Report of proposed sale of securities
22/12/202315:29EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
19/12/202306:30BWZai Lab Announces Participation in January Investor..
18/12/202316:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/12/202307:53GLOBEParatek Pharmaceuticals Announces Inclusion of Oral NUZYRA®..
12/12/202322:10BWZai Lab Announces the First Listing of VYVGART®..
16/11/202317:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202315:10EDGAR2Form 8-K - Current report
07/11/202315:05GLOBEZai Lab Announces Third Quarter 2023 Financial Results and..
03/11/202315:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202314:20EDGAR2Form 144 - Report of proposed sale of securities
26/10/202306:30GLOBEZai Lab Announces Participation in November Investor..
18/10/202306:30GLOBEZai Lab to Announce Third Quarter 2023 Financial Results and..
03/10/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202306:30GLOBEZai Lab Obtains Breakthrough Therapy Designation for..
08/9/202305:12EDGAR2Form 144 - Report of proposed sale of securities
30/8/202306:30GLOBEZai Lab Announces Breakthrough Therapy Designation Granted..
29/8/202306:38GLOBEZai Lab Announces Participation in September Investor..
21/8/202315:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/8/202315:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ZLAB
Zai Lab
COIN
FISUSD
StaFi (rToken)
BIT
P1LT55
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados